Page 1 of Clinical Trials for Tibotec BVBA [SPONSOR-COLLABORATORS], 20 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
VX-950-TiDP24-C216: A Safety and Efficacy Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment
Last Updated: July 18, 2011
Condition(s): Hepatitis C, Chronic
2
Completed
VX-950-TiDP24-C210: A Study to Assess the Activity of Telaprevir on Hepatitis C Virus in Treatment Naive Patients Who Are Chronically Infected With Hepatitis C Genotype 4 Infection
Last Updated: December 16, 2010
Condition(s): Hepatitis C, Chronic
3
Completed
TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP)
Last Updated: July 8, 2010
Condition(s): HIV Infections
4
Completed
VX-950-TiDP24-C209: A Phase 2a Partially Blinded Clinical Study to Evaluate the Viral Kinetics and Safety of Telaprevir in Patients With Genotype 2 or 3 Infection.
Last Updated: December 23, 2010
Condition(s): Hepatitis C, Chronic
5
Terminated
TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin
Last Updated: April 6, 2012
Condition(s): Hepatitis C Virus
6
Completed
VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.
Last Updated: December 16, 2010
Condition(s): Hepatitis C; Telaprevir; HIV
7
Completed
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
Last Updated: April 26, 2010
Condition(s): Tuberculosis
8
Completed
VX-950-TiDP24-C208: An Open-label Study of Telaprevir Administered Every 12 or Every 8 Hours in Combination With Standard Treatment in Treatment Naive Patients With Chronic Genotype 1 Hepatitis C
Last Updated: December 16, 2010
Condition(s): Hepatitis C, Chronic
9
Completed
TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer
Last Updated: April 26, 2010
Condition(s): Tuberculosis; HIV
10
Not yet recruiting
An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic HCV-1 and HIV-1
Last Updated: January 19, 2012
Condition(s): Genotype 1 Chronic Hepatitis C; Treatment naïve With HCV-1/HIV-1 Coinfection; Treatment Experienced With HCV-1/HIV-1 Coinfection
11
Completed
TMC207-TiDP13-C111: Trial With Healthy Volunteers to Determine the Levels of TMC207 in Blood After a Single Orale Dose of TMC207
Last Updated: May 28, 2010
Condition(s): Tuberculosis
12
Completed
VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Last Updated: November 4, 2011
Condition(s): Hepatitis C
13
Completed
TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed Conditions
Last Updated: November 28, 2011
Condition(s): Healthy Volunteer
14
Completed
VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.
Last Updated: December 16, 2010
Condition(s): Hepatitis C; Kidney Diseases
15
Completed
VX-950-TiDP24-C135: Drug-drug Interaction Trial Between Telaprevir and Methadone.
Last Updated: December 16, 2010
Condition(s): Hepatitis C
16
Completed
TMC207-TiDP13-C112 - A Study to Investigate Pharmacokinetics, Safety and Tolerability of TMC207 in Patients With Moderately Impaired Hepatic Function
Last Updated: January 27, 2011
Condition(s): Tuberculosis; Liver Diseases
17
Completed
VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers
Last Updated: December 16, 2010
Condition(s): Hepatitis C
18
Completed
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer
Last Updated: December 16, 2010
Condition(s): Hepatitis C; HCV; HIV; AIDS
19
Completed
VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram
Last Updated: December 16, 2010
Condition(s): Hepatitis C
20
Completed
Drug-Drug Interaction Study Between Telaprevir and Buprenorphine
Last Updated: June 7, 2011
Condition(s): Hepatitis C; Opioid-Related Disorders

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Tibotec+BVBA

Page 1 of Clinical Trials for Tibotec BVBA [SPONSOR-COLLABORATORS], 20 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About